166su Researcher Studying Probiotics to Fight Acid Reflux, Esophageal Cancer Associate Professor Claudia Andl is examining how a simple probiotic can treat the damage from acid reflux disease, a condition that affects one-fourth of Americans and increases their risk for esophageal cancer.
166su Scientist Leads Research to Break Through Harmful Bacterial “Fortresses” Continuing her work with antibiotic-resistant bacteria, Renee Fleeman is understanding how a bioengineered peptide can curb severe infections for patients.
166su Researcher Develops “Smart, Tiny Bubbles” to Treat Cancer and Heart Disease Dinender Singla developed innovative technology and has formed a company to get the treatment ready for clinical trials.
166su Graduates 109 New Physician Knights New doctors go onto residency training at leading programs across Orlando, state and nation.
166su Scientist Sends Blood Clotting Research to Space Hansjorg Schwertz joins the College of Medicine’s Space Medicine team a day before SpaceX 34 is set to launch with his experiment onboard.
166su’s Spring 2026 Commencement Set for May 8–9 Graduates will hear from distinguished speakers who’ve made significant contributions in space, higher education, healthcare, technology and business.
4 Knights Named Goldwater Scholars, Elevating 166su to a Historic National Milestone The four recipients are bridging the gap between cutting-edge lab research and real-world impact in engineering, medicine and science to solve global challenges.
166su, Industry Experts Share Insight on Evolution of Space Medicine As NASA continues to advance the Artemis program, UCF researchers and space experts are collaborating to ensure future travelers to the moon, Mars stay safe and healthy.
166su Recognizes Faculty Excellence With 2026 Promotion and Tenure Awards One hundred faculty members are recognized for excellence in teaching, research and service.
166su Expert Plays Key Role in International Research to Combat Dengue Fever, Zika As a mosquito-borne virus expert, UCF Assistant Professor James Earnest is leveraging his knowledge to lead two research projects studying immune responses to the dengue and Zika viruses.